Overview: Coxsackie A Antibody TestIntroduction: The Coxsackie A Antibody Test detects antibodies to Coxsackie A virus, linked to infections causing fever, rash, or heart inflammation. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in immunology for patients with suspected viral infections.
Other Names: Coxsackie A Ab Assay, Viral Infection Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Coxsackie antibody testing began in the 1960s with viral research. Immunoassays emerged in the 1980s, and by the 2000s, high-sensitivity assays improved diagnostic accuracy.
Purpose: Diagnoses Coxsackie A infection, guides treatment, and monitors antibody levels in patients with fever, rash, or heart inflammation.
Test Parameters: 1. Coxsackie A Antibodies
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like fever, rash, or chest pain, and list recent infections or travel.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, rash, heart inflammation, or recent viral exposure. Include current medications, especially antivirals or steroids.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral or supportive therapy.
Procedural Considerations: Uses an immunoassay to measure Coxsackie A antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Cross-reactivity with other enteroviruses may cause false positives. Hemolysis or improper storage can degrade samples.
Clinical Significance: Positive results confirm Coxsackie A infection, prompting supportive therapy. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A cardiologist referral is advised for heart inflammation cases.
Additional Supporting Tests: Coxsackie PCR, echocardiogram, or viral culture to confirm infection or assess complications.
Test Limitations: False positives may occur with related viruses. Results require clinical correlation with symptoms.
References: IDSA Viral Infection Guidelines, 2023; Clinical Infectious Diseases, Pallansch MA, 2022.
